148 related articles for article (PubMed ID: 29587622)
21. Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamster.
King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Zhao G; Mittelstadt SW; Cox BF
J Pharmacol Exp Ther; 2009 Aug; 330(2):526-31. PubMed ID: 19478132
[TBL] [Abstract][Full Text] [Related]
22. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
[TBL] [Abstract][Full Text] [Related]
23. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
24. Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models.
Kim MK; Chae YN; Ahn GJ; Shin CY; Choi SH; Yang EK; Sohn YS; Son MH
Arch Pharm Res; 2017 Feb; 40(2):268-281. PubMed ID: 27885461
[TBL] [Abstract][Full Text] [Related]
25. 5-HT 2 receptor mediates high-fat diet-induced hepatic steatosis and very low density lipoprotein overproduction in rats.
Li X; Guo K; Li T; Ma S; An S; Wang S; Di J; He S; Fu J
Obes Res Clin Pract; 2018; 12(Suppl 2):16-28. PubMed ID: 27133527
[TBL] [Abstract][Full Text] [Related]
26. Zucker Lean Rats With Hepatic Steatosis Recapitulate Asymptomatic Metabolic Syndrome and Exhibit Greater Sensitivity to Drug-Induced Liver Injury Compared With Standard Nonclinical Sprague-Dawley Rat Model.
LaBranche TP; Kopec AK; Mantena SR; Hollingshead BD; Harrington AW; Stewart ZS; Zhan Y; Hayes KD; Whiteley LO; Burdick AD; Davis JW
Toxicol Pathol; 2020 Dec; 48(8):994-1007. PubMed ID: 33252024
[TBL] [Abstract][Full Text] [Related]
27. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats.
Crescenzo R; Bianco F; Coppola P; Mazzoli A; Tussellino M; Carotenuto R; Liverini G; Iossa S
Exp Physiol; 2014 Sep; 99(9):1203-13. PubMed ID: 24972835
[TBL] [Abstract][Full Text] [Related]
28. Dimethylarginine Dimethylaminohydrolase 1 Protects Against High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
Li T; Feng R; Zhao C; Wang Y; Wang J; Liu S; Cao J; Wang H; Wang T; Guo Y; Lu Z
Antioxid Redox Signal; 2017 Apr; 26(11):598-609. PubMed ID: 27565538
[TBL] [Abstract][Full Text] [Related]
29. Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2008 Feb; 47(2):625-35. PubMed ID: 18000880
[TBL] [Abstract][Full Text] [Related]
30. Diacylglycerol acyltransferase-1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats.
Schober G; Arnold M; Birtles S; Buckett LK; Pacheco-López G; Turnbull AV; Langhans W; Mansouri A
J Lipid Res; 2013 May; 54(5):1369-84. PubMed ID: 23449193
[TBL] [Abstract][Full Text] [Related]
31. Trivalent chromium alleviates oleic acid induced steatosis in SMMC-7721 cells by decreasing fatty acid uptake and triglyceride synthesis.
Wang S; Wang J; Zhang X; Hu L; Fang Z; Huang Z; Shi P
Biometals; 2016 Oct; 29(5):881-92. PubMed ID: 27497686
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
33. Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathways.
Larter CZ; Yeh MM; Haigh WG; Williams J; Brown S; Bell-Anderson KS; Lee SP; Farrell GC
J Hepatol; 2008 Apr; 48(4):638-47. PubMed ID: 18280001
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice.
Gluchowski NL; Gabriel KR; Chitraju C; Bronson RT; Mejhert N; Boland S; Wang K; Lai ZW; Farese RV; Walther TC
Hepatology; 2019 Dec; 70(6):1972-1985. PubMed ID: 31081165
[TBL] [Abstract][Full Text] [Related]
35. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
[TBL] [Abstract][Full Text] [Related]
36. FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet.
Kim DH; Lee S; Noh SG; Lee J; Chung HY
Aging (Albany NY); 2024 Mar; 16(5):4095-4115. PubMed ID: 38441531
[TBL] [Abstract][Full Text] [Related]
37. A novel low systemic diacylglycerol acyltransferase 1 inhibitor, Yhhu2407, improves lipid metabolism.
Huang JS; Guo BB; Lin FF; Zeng LM; Wang T; Dang XY; Yang Y; Hu YH; Liu J; Wang HY
Eur J Pharm Sci; 2021 Mar; 158():105683. PubMed ID: 33347980
[TBL] [Abstract][Full Text] [Related]
38. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c.
Zhang J; Tan Y; Yao F; Zhang Q
Mol Med Rep; 2012 Oct; 6(4):815-20. PubMed ID: 22858825
[TBL] [Abstract][Full Text] [Related]
39. Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention.
Helal MG; Ayoub SE; Elkashefand WF; Ibrahim TM
Hum Exp Toxicol; 2018 Sep; 37(9):983-990. PubMed ID: 29249184
[TBL] [Abstract][Full Text] [Related]
40. Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice.
Ahmed O; Pramfalk C; Pedrelli M; Olin M; Steffensen KR; Eriksson M; Parini P
Dig Liver Dis; 2019 Jul; 51(7):1016-1022. PubMed ID: 30630736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
